Antidepressant Pharmacotherapy: Considerations for the Pain Clinician
- 5 June 2003
- journal article
- Published by Wiley in Pain Practice
- Vol. 3 (2) , 135-143
- https://doi.org/10.1046/j.1533-2500.2003.03020.x
Abstract
Antidepressant pharmacotherapy presents many challenges to clinicians dealing with patients suffering from chronic pain. Co-existent depression and pain continues to present clinicians with a plethora of difficult treatment selections. Treated in isolation, each of these disease states can prove difficult to treat. Collectively, depression and pain often present significantly more difficult challenges to the clinician. Antidepressants may be used as a primary treatment modality for depression in a patient dealing with chronic pain. At other times these agents may be used to treat certain specific chronic pain syndromes, possibly in the face of concomitant depression. Clinicians should be aware of the many peculiarities associated with this broad class of medications. Included in this review are considerations for drug selection, dose escalation, and common drug related problems (eg, adverse drug reactions). In addition, attention is paid to the appropriate selection of an agent for use in either the primary management of pain or depression.Keywords
This publication has 29 references indexed in Scilit:
- Optimal antidepressant dosingPostgraduate Medicine, 2000
- Recognition and Management of Depression in Primary CareClinical Journal of Sport Medicine, 2000
- The efficacy of newer antidepressants in the treatment of chronic pain: a review of current literatureHarvard Review of Psychiatry, 2000
- Depression in Palliative Care PatientsJournal of Pharmaceutical Care in Pain & Symptom Control, 2000
- Systematic Review and Guide to Selection of Selective Serotonin Reuptake InhibitorsDrugs, 1999
- Pharmacokinetic-Pharmacodynamic Relationship of the Selective Serotonin Reuptake Inhibitors???Clinical Pharmacokinetics, 1996
- A systematic review of antidepressants in neuropathic painPain, 1996
- TrazodoneDrugs & Aging, 1994
- Risk-Benefit Assessment of Newer Versus Older Monoamine Oxidase (MAO) InhibitorsDrug Safety, 1994
- The treatment of depression in chronic low back pain: review and recommendationsPain, 1992